ACS NANO, ISSN 1936-0851, 02/2019, Volume 13, Issue 2, pp. 2450 - 2462
Insulin resistance is the major pathological characteristic of type 2 diabetes, and the elderly often develop insulin resistance. However, the deep-seated...
HOMEOSTASIS | BM-MSCs | MATERIALS SCIENCE, MULTIDISCIPLINARY | CHEMISTRY, PHYSICAL | NANOSCIENCE & NANOTECHNOLOGY | MECHANISMS | MICRORNAS | SUPPRESSION | SIRT1 | CHEMISTRY, MULTIDISCIPLINARY | METABOLISM | OSTEOCALCIN | MASS | microRNA | MIRNAS | insulin resistance | exosome | EXPRESSION | INSIGHTS
HOMEOSTASIS | BM-MSCs | MATERIALS SCIENCE, MULTIDISCIPLINARY | CHEMISTRY, PHYSICAL | NANOSCIENCE & NANOTECHNOLOGY | MECHANISMS | MICRORNAS | SUPPRESSION | SIRT1 | CHEMISTRY, MULTIDISCIPLINARY | METABOLISM | OSTEOCALCIN | MASS | microRNA | MIRNAS | insulin resistance | exosome | EXPRESSION | INSIGHTS
Journal Article
Cell Transplantation, ISSN 0963-6897, 9/2017, Volume 26, Issue 9, pp. 1520 - 1529
Aging at the cellular level is a complex process resulting from accumulation of various damages leading to functional impairment and a reduced quality of life...
bone marrow (BM) | in vitro | mesenchymal stromal cells (MSCs) | in vivo | aging | Original
bone marrow (BM) | in vitro | mesenchymal stromal cells (MSCs) | in vivo | aging | Original
Journal Article
Cellular and Molecular Life Sciences, ISSN 1420-682X, 2015, Volume 72, Issue 8, pp. 1517 - 1536
Megakaryocytes are rare cells found in the bone marrow, responsible for the everyday production and release of millions of platelets into the bloodstream....
Bone marrow (BM) | Megakaryocytes (Mk) | Fibrosis | Thrombopoietin (Thpo) | Extracellular matrices (ECMs) | Osteoblasts | Endothelial cells | Myeloproliferative diseases | Vascular niche | PROGENITOR CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MYELOPROLIFERATIVE NEOPLASMS | ESSENTIAL THROMBOCYTHEMIA | CELL BIOLOGY | GROWTH-FACTOR-BETA | IN-VITRO | HEMATOPOIETIC STEM-CELLS | ENDOTHELIAL-CELLS | ACUTE MEGAKARYOBLASTIC LEUKEMIA | PLATELET ALPHA-GRANULES | PROPLATELET FORMATION | Thrombopoietin - metabolism | Bone Marrow Cells - cytology | Humans | Extracellular Matrix - metabolism | Mesenchymal Stromal Cells - metabolism | Hematopoietic Stem Cells - metabolism | Thrombocytopenia - pathology | Thrombocytopenia - metabolism | Mesenchymal Stromal Cells - cytology | Animals | Blood Platelets - metabolism | Bone Marrow - metabolism | Hematopoietic Stem Cells - cytology | Megakaryocytes - cytology | Megakaryocytes - metabolism | Bone Marrow Cells - metabolism | Homeostasis | Biomedical engineering | Bone marrow | Disease control | Cells | Blood | Endothelial Cells | Myeloproliferative Diseases | Bone Marrow (BM) | Extracellular Matrices (ECMs) | Vascular Niche
Bone marrow (BM) | Megakaryocytes (Mk) | Fibrosis | Thrombopoietin (Thpo) | Extracellular matrices (ECMs) | Osteoblasts | Endothelial cells | Myeloproliferative diseases | Vascular niche | PROGENITOR CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MYELOPROLIFERATIVE NEOPLASMS | ESSENTIAL THROMBOCYTHEMIA | CELL BIOLOGY | GROWTH-FACTOR-BETA | IN-VITRO | HEMATOPOIETIC STEM-CELLS | ENDOTHELIAL-CELLS | ACUTE MEGAKARYOBLASTIC LEUKEMIA | PLATELET ALPHA-GRANULES | PROPLATELET FORMATION | Thrombopoietin - metabolism | Bone Marrow Cells - cytology | Humans | Extracellular Matrix - metabolism | Mesenchymal Stromal Cells - metabolism | Hematopoietic Stem Cells - metabolism | Thrombocytopenia - pathology | Thrombocytopenia - metabolism | Mesenchymal Stromal Cells - cytology | Animals | Blood Platelets - metabolism | Bone Marrow - metabolism | Hematopoietic Stem Cells - cytology | Megakaryocytes - cytology | Megakaryocytes - metabolism | Bone Marrow Cells - metabolism | Homeostasis | Biomedical engineering | Bone marrow | Disease control | Cells | Blood | Endothelial Cells | Myeloproliferative Diseases | Bone Marrow (BM) | Extracellular Matrices (ECMs) | Vascular Niche
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 07/2019, Volume 234, Issue 7, pp. 11276 - 11286
Cancer chemotherapy can cause significant damage to the bone marrow (BM) microvascular (sinusoidal) system. Investigations must now address whether and how BM...
apoptosis | genistein | bone marrow sinusoidal endothelial cells (BM SECs) | angiogenesis | CELLS | PHYSIOLOGY | NITRIC-OXIDE SYNTHASE | REGENERATION | MECHANISMS | CHEMOTHERAPY | CELL BIOLOGY | HEMATOPOIESIS | DIFFERENTIATION | PHYTOESTROGEN GENISTEIN | EXPRESSION | Methotrexate | Vascular endothelial growth factor | Nitric oxide | Isoflavones | Soybeans | Genistein | Blood vessels | Cytotoxicity | Osteoblasts | Nitric-oxide synthase | Endothelial cells | Angiogenesis | Chemotherapy | Biomedical materials | Flavonoids | Bone cancer | Rodents | Bone marrow | Biocompatibility | Microvasculature | Damage | Growth factors | Cancer | Apoptosis
apoptosis | genistein | bone marrow sinusoidal endothelial cells (BM SECs) | angiogenesis | CELLS | PHYSIOLOGY | NITRIC-OXIDE SYNTHASE | REGENERATION | MECHANISMS | CHEMOTHERAPY | CELL BIOLOGY | HEMATOPOIESIS | DIFFERENTIATION | PHYTOESTROGEN GENISTEIN | EXPRESSION | Methotrexate | Vascular endothelial growth factor | Nitric oxide | Isoflavones | Soybeans | Genistein | Blood vessels | Cytotoxicity | Osteoblasts | Nitric-oxide synthase | Endothelial cells | Angiogenesis | Chemotherapy | Biomedical materials | Flavonoids | Bone cancer | Rodents | Bone marrow | Biocompatibility | Microvasculature | Damage | Growth factors | Cancer | Apoptosis
Journal Article
Andrologia, ISSN 0303-4569, 05/2019, Volume 51, Issue 4, pp. e13229 - n/a
Bone marrow mesenchymal stem cells (BM‐MSCs) were first cultured under induction of retinoic acid (RA), Sertoli cells conditioned medium and RA + con...
spermatogenesis | apoptosis | differentiation | BM‐MSCs | BM-MSCs | RETINOIC ACID | ANDROLOGY | PROLIFERATION | PARAMETERS | INDUCTION | COCULTURE | CONDITIONED MEDIUM | Cell Survival | Cells, Cultured | Mesenchymal Stem Cells - physiology | Bone Marrow Cells - physiology | Male | Cell Culture Techniques - methods | Germ Cells - physiology | Sertoli Cells | Culture Media, Conditioned | Animals | Flow Cytometry | Tretinoin - metabolism | Infertility, Male - therapy | Cell Differentiation | Mice | Cell differentiation | Gene expression | Stem cells | Cell culture | Flow cytometry | Mesenchyme | Immunocytochemistry | Oct-4 protein | Cytology | Sertoli cells | Polymerase chain reaction | DNA fragmentation | Bone marrow | Retinoic acid | Cytoplasm | Apoptosis
spermatogenesis | apoptosis | differentiation | BM‐MSCs | BM-MSCs | RETINOIC ACID | ANDROLOGY | PROLIFERATION | PARAMETERS | INDUCTION | COCULTURE | CONDITIONED MEDIUM | Cell Survival | Cells, Cultured | Mesenchymal Stem Cells - physiology | Bone Marrow Cells - physiology | Male | Cell Culture Techniques - methods | Germ Cells - physiology | Sertoli Cells | Culture Media, Conditioned | Animals | Flow Cytometry | Tretinoin - metabolism | Infertility, Male - therapy | Cell Differentiation | Mice | Cell differentiation | Gene expression | Stem cells | Cell culture | Flow cytometry | Mesenchyme | Immunocytochemistry | Oct-4 protein | Cytology | Sertoli cells | Polymerase chain reaction | DNA fragmentation | Bone marrow | Retinoic acid | Cytoplasm | Apoptosis
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 02/2019, Volume 234, Issue 2, pp. 1913 - 1924
Decreasing bone marrow (BM) microvessel density and circulating angiogenic cytokine levels are promising strategies for the treatment of relapsed and resistant...
acute myeloid leukemia (AML) | bone marrow (BM) angiogenesis | wogonoside | interleukin‐8 (IL‐8) | STAT3 | interleukin-8 (IL-8) | PHYSIOLOGY | BEVACIZUMAB | ACUTE MYELOGENOUS LEUKEMIA | CANCER | INTERLEUKIN-8 | CELL BIOLOGY | AML CELLS | THERAPY | MICROENVIRONMENT | PATHWAY | BLASTS | DIFFERENTIATION | Interleukins | Cytokines | Poultry | Myeloid leukemia | Leukemia | Interleukin | Crosstalk | Stat3 protein | Malignancy | Positive feedback | Angiogenesis | Chorioallantoic membrane | Janus kinase 2 | Stromal cells | Bone marrow | Bone density | Solid tumors | Acute myeloid leukemia | Tumors | Index Medicus
acute myeloid leukemia (AML) | bone marrow (BM) angiogenesis | wogonoside | interleukin‐8 (IL‐8) | STAT3 | interleukin-8 (IL-8) | PHYSIOLOGY | BEVACIZUMAB | ACUTE MYELOGENOUS LEUKEMIA | CANCER | INTERLEUKIN-8 | CELL BIOLOGY | AML CELLS | THERAPY | MICROENVIRONMENT | PATHWAY | BLASTS | DIFFERENTIATION | Interleukins | Cytokines | Poultry | Myeloid leukemia | Leukemia | Interleukin | Crosstalk | Stat3 protein | Malignancy | Positive feedback | Angiogenesis | Chorioallantoic membrane | Janus kinase 2 | Stromal cells | Bone marrow | Bone density | Solid tumors | Acute myeloid leukemia | Tumors | Index Medicus
Journal Article
Neuroscience Letters, ISSN 0304-3940, 01/2015, Volume 584, pp. 97 - 102
Resveratrol-3,4′,5-trihydroxy- -stillbene (resveratrol; RSV), a natural non-flavonoid polyphenol compound, provides protection against stress injury, excessive...
Neuronal differentiation | Sirtuin1 (SIRT1) | Bone marrow mesenchymal stem cells (BM-MSCs) | Resveratrol | SURVIVAL | SIRTUINS | NEUROSCIENCES | NEURODEGENERATIVE DISEASES | INHIBITION | NEURITE OUTGROWTH | PATHWAY | MICE | STROMAL CELLS | PROTEINS | SMALL-MOLECULE ACTIVATORS | Biomarkers - metabolism | Sirtuin 1 - metabolism | Mesenchymal Stromal Cells - cytology | Bone Marrow Cells - cytology | Humans | Cells, Cultured | Mesenchymal Stromal Cells - metabolism | Neurons - cytology | Cell Differentiation | Neurons - metabolism | Stilbenes - pharmacology | Bone Marrow Cells - metabolism | Control systems | Neurons | Stem cells
Neuronal differentiation | Sirtuin1 (SIRT1) | Bone marrow mesenchymal stem cells (BM-MSCs) | Resveratrol | SURVIVAL | SIRTUINS | NEUROSCIENCES | NEURODEGENERATIVE DISEASES | INHIBITION | NEURITE OUTGROWTH | PATHWAY | MICE | STROMAL CELLS | PROTEINS | SMALL-MOLECULE ACTIVATORS | Biomarkers - metabolism | Sirtuin 1 - metabolism | Mesenchymal Stromal Cells - cytology | Bone Marrow Cells - cytology | Humans | Cells, Cultured | Mesenchymal Stromal Cells - metabolism | Neurons - cytology | Cell Differentiation | Neurons - metabolism | Stilbenes - pharmacology | Bone Marrow Cells - metabolism | Control systems | Neurons | Stem cells
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 12/2018, Volume 233, Issue 12, pp. 9159 - 9166
Obesity has become a global epidemic influencing the establishment and progression of a wide range of diseases, such as diabetes, cardiovascular disease, and...
adiponectin | adipokines | bone marrow (BM) adipocytes | multiple myeloma (MM) | obesity | PHYSIOLOGY | CELL BIOLOGY | BREAST-CANCER | PLASMA ADIPONECTIN | INSULIN-RESISTANCE | CALORIC RESTRICTION | PROSTATE-CANCER | BODY-MASS INDEX | POOLED ANALYSIS | PHYSICAL-ACTIVITY | CIRCULATING ADIPONECTIN | Development and progression | Leptin | Multiple myeloma | Epidemics | Obesity | Cell survival | Adipose tissue | Body fat | Secretion | Diabetes mellitus | Monoclonal gammopathy | Gammopathy | Inflammation | Adipocytes | Risk analysis | Risk factors | Adiponectin | Bone cancer | Bone marrow | Plasma cells | Cardiovascular diseases | Health risk assessment | Cell migration | Cancer | Refueling
adiponectin | adipokines | bone marrow (BM) adipocytes | multiple myeloma (MM) | obesity | PHYSIOLOGY | CELL BIOLOGY | BREAST-CANCER | PLASMA ADIPONECTIN | INSULIN-RESISTANCE | CALORIC RESTRICTION | PROSTATE-CANCER | BODY-MASS INDEX | POOLED ANALYSIS | PHYSICAL-ACTIVITY | CIRCULATING ADIPONECTIN | Development and progression | Leptin | Multiple myeloma | Epidemics | Obesity | Cell survival | Adipose tissue | Body fat | Secretion | Diabetes mellitus | Monoclonal gammopathy | Gammopathy | Inflammation | Adipocytes | Risk analysis | Risk factors | Adiponectin | Bone cancer | Bone marrow | Plasma cells | Cardiovascular diseases | Health risk assessment | Cell migration | Cancer | Refueling
Journal Article
Nature Medicine, ISSN 1078-8956, 05/2018, Volume 24, Issue 4, pp. 450 - 462
Leukemia stem cells (LSCs) in individuals with chronic myelogenous leukemia (CML) (hereafter referred to as CML LSCs) are responsible for initiating and...
MEDICINE, RESEARCH & EXPERIMENTAL | ANGIOGENESIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MICRORNA MIR-126 | ACUTE MYELOID-LEUKEMIA | CELL BIOLOGY | NANOPARTICLES | ENDOTHELIAL-CELLS | IN-VIVO | VASCULAR INTEGRITY | LEUKEMOGENESIS | EXPRESSION | HEMATOPOIETIC STEM | Care and treatment | MicroRNA | Stem cells | Bone marrow | Development and progression | Genetic aspects | Chronic myeloid leukemia | Gene expression | Health aspects | BCR protein | Tyrosine | Phosphorylation | Animal models | Myeloid leukemia | Leukemia | Trafficking | MiRNA | Stem cell transplantation | Abl protein | Kinases | Hematopoietic stem cells | Endothelial cells | Allografts | Ribonucleic acids | Hematopoiesis | Rodents | Inhibition | Fusion protein | Protein-tyrosine kinase | microRNA | chemoresistance | CML | LSC | BM niche
MEDICINE, RESEARCH & EXPERIMENTAL | ANGIOGENESIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MICRORNA MIR-126 | ACUTE MYELOID-LEUKEMIA | CELL BIOLOGY | NANOPARTICLES | ENDOTHELIAL-CELLS | IN-VIVO | VASCULAR INTEGRITY | LEUKEMOGENESIS | EXPRESSION | HEMATOPOIETIC STEM | Care and treatment | MicroRNA | Stem cells | Bone marrow | Development and progression | Genetic aspects | Chronic myeloid leukemia | Gene expression | Health aspects | BCR protein | Tyrosine | Phosphorylation | Animal models | Myeloid leukemia | Leukemia | Trafficking | MiRNA | Stem cell transplantation | Abl protein | Kinases | Hematopoietic stem cells | Endothelial cells | Allografts | Ribonucleic acids | Hematopoiesis | Rodents | Inhibition | Fusion protein | Protein-tyrosine kinase | microRNA | chemoresistance | CML | LSC | BM niche
Journal Article
OncoTargets and Therapy, ISSN 1178-6930, 08/2017, Volume 10, pp. 4161 - 4171
Worldwide, gastric cancer (GC) is one of the deadliest malignant tumors of the digestive system. Moreover, microRNAs (miRNAs) of exosomes harbored within...
Prognosis | Exosomes | Gastric cancer | BM-MSCs | Oncogenic activity | MiR-221 | METASTASIS | gastric cancer | STATISTICS | oncogenic activity | MICRORNAS | RELEASE | prognosis | MULTIVESICULAR BODIES | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | exosomes | miR-221 | PROSTATE-CANCER | RESISTANCE | PROGRESSION | Care and treatment | MicroRNA | Development and progression | Genetic aspects | Gene expression | Stomach cancer | Health aspects | Medical research | Cell culture | Laboratories | Colorectal cancer | Roles | Metastasis | Drug resistance | Medicine | Liver cancer | Cell growth | MicroRNAs | Stem cells | Biomarkers | Bone marrow | Tumors
Prognosis | Exosomes | Gastric cancer | BM-MSCs | Oncogenic activity | MiR-221 | METASTASIS | gastric cancer | STATISTICS | oncogenic activity | MICRORNAS | RELEASE | prognosis | MULTIVESICULAR BODIES | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | exosomes | miR-221 | PROSTATE-CANCER | RESISTANCE | PROGRESSION | Care and treatment | MicroRNA | Development and progression | Genetic aspects | Gene expression | Stomach cancer | Health aspects | Medical research | Cell culture | Laboratories | Colorectal cancer | Roles | Metastasis | Drug resistance | Medicine | Liver cancer | Cell growth | MicroRNAs | Stem cells | Biomarkers | Bone marrow | Tumors
Journal Article
Tissue Engineering Part A, ISSN 1937-3341, 01/2018, Volume 24, Issue 1-2, pp. 135 - 144
Objective: Electrospinning is a promising technology that provides biodegradable nanofiber scaffolds for cardiovascular tissue engineering. However, success...
Original Articles | Tissue-engineered vascular graft (TEVG) | biodegradable scaffold | bone marrow mononuclear cell (BM-MNC) seeding | electrospinning | stenosis | nanofiber | SYSTEM | MOUSE | VENOUS THROMBOSIS | NEOVESSEL FORMATION | AUTOGRAFTS | tissue-engineered vascular graft (TEVG) | MODEL | CELL & TISSUE ENGINEERING | CELL BIOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCAFFOLDS | POLARIZATION | NEXT-GENERATION | Immunohistochemistry | Animals | Tissue Engineering - methods | Bone Marrow Cells - cytology | Mice, Inbred C57BL | Cells, Cultured | Female | Mice | Blood Vessel Prosthesis | Tissue Scaffolds - chemistry | Syngeneic grafts | Biodegradability | Heart surgery | Stenosis | Electrospinning | Thrombin | Smooth muscle | Cardiovascular disease | Activation | Macrophages | Seeding | Grafting | Design optimization | Polyglycolic acid | Biomedical materials | Cell activation | Ultrasonography | Bone marrow | Extracellular matrix | Deoxyribonucleic acid--DNA | Biodegradation | Scanning electron microscopy | Polymer blends | Tissue engineering | Secretion | Muscles | Histology | Inflammation | Electron microscopy | Thrombosis | Children & youth | Grafts | Collagen | Stem cells | Infiltration | Bone | Nanofibers | Laboratory animals | Platelets | ATP | Scaffolds | Original
Original Articles | Tissue-engineered vascular graft (TEVG) | biodegradable scaffold | bone marrow mononuclear cell (BM-MNC) seeding | electrospinning | stenosis | nanofiber | SYSTEM | MOUSE | VENOUS THROMBOSIS | NEOVESSEL FORMATION | AUTOGRAFTS | tissue-engineered vascular graft (TEVG) | MODEL | CELL & TISSUE ENGINEERING | CELL BIOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCAFFOLDS | POLARIZATION | NEXT-GENERATION | Immunohistochemistry | Animals | Tissue Engineering - methods | Bone Marrow Cells - cytology | Mice, Inbred C57BL | Cells, Cultured | Female | Mice | Blood Vessel Prosthesis | Tissue Scaffolds - chemistry | Syngeneic grafts | Biodegradability | Heart surgery | Stenosis | Electrospinning | Thrombin | Smooth muscle | Cardiovascular disease | Activation | Macrophages | Seeding | Grafting | Design optimization | Polyglycolic acid | Biomedical materials | Cell activation | Ultrasonography | Bone marrow | Extracellular matrix | Deoxyribonucleic acid--DNA | Biodegradation | Scanning electron microscopy | Polymer blends | Tissue engineering | Secretion | Muscles | Histology | Inflammation | Electron microscopy | Thrombosis | Children & youth | Grafts | Collagen | Stem cells | Infiltration | Bone | Nanofibers | Laboratory animals | Platelets | ATP | Scaffolds | Original
Journal Article
Journal of Biomedical Materials Research Part A, ISSN 1549-3296, 03/2018, Volume 106, Issue 3, pp. 829 - 838
Bone marrow derived mesenchymal stem cells (BM‐MSC) is a promising alternative cell source to primary hepatocytes because of their ability to differentiate...
in vitro cell culture | liver ECM | BM‐MSCs | hepatic differentiation | BM-MSCs | MATERIALS SCIENCE, BIOMATERIALS | ENGINEERING, BIOMEDICAL | REGENERATION | INDUCTION | MATURATION | CULTURE | GEL | TRANSPLANTATION | MAINTENANCE | IN-VITRO | HUMAN HEPATOCYTES | EXTRACELLULAR-MATRIX | Humans | Extracellular Matrix - metabolism | Hepatocytes - metabolism | Hepatocytes - cytology | Mesenchymal Stem Cells - cytology | Mesenchymal Stem Cells - drug effects | Bone Marrow Cells - drug effects | Urea - metabolism | Lipoproteins, LDL - metabolism | Mesenchymal Stem Cells - metabolism | Hepatocytes - drug effects | alpha-Fetoproteins - metabolism | Cell Survival - drug effects | Bone Marrow Cells - cytology | Extracellular Matrix - drug effects | Liver - metabolism | Rats, Sprague-Dawley | Cell Shape - drug effects | Gene Expression Regulation - drug effects | Animals | Cell Differentiation - drug effects | Cell Proliferation - drug effects | Gelatin - metabolism | Hydrogels - pharmacology | Bone Marrow Cells - metabolism | Serum Albumin - metabolism | Transplantation | Cell differentiation | Low density lipoproteins | Stem cells | Cell culture | Hydrogels | Mesenchyme | Liver | Gelation | Differentiation (biology) | Albumin | mRNA | α-Fetoprotein | Urea | Hepatocytes | Bone marrow | Extracellular matrix | Bone | Coating | Viability
in vitro cell culture | liver ECM | BM‐MSCs | hepatic differentiation | BM-MSCs | MATERIALS SCIENCE, BIOMATERIALS | ENGINEERING, BIOMEDICAL | REGENERATION | INDUCTION | MATURATION | CULTURE | GEL | TRANSPLANTATION | MAINTENANCE | IN-VITRO | HUMAN HEPATOCYTES | EXTRACELLULAR-MATRIX | Humans | Extracellular Matrix - metabolism | Hepatocytes - metabolism | Hepatocytes - cytology | Mesenchymal Stem Cells - cytology | Mesenchymal Stem Cells - drug effects | Bone Marrow Cells - drug effects | Urea - metabolism | Lipoproteins, LDL - metabolism | Mesenchymal Stem Cells - metabolism | Hepatocytes - drug effects | alpha-Fetoproteins - metabolism | Cell Survival - drug effects | Bone Marrow Cells - cytology | Extracellular Matrix - drug effects | Liver - metabolism | Rats, Sprague-Dawley | Cell Shape - drug effects | Gene Expression Regulation - drug effects | Animals | Cell Differentiation - drug effects | Cell Proliferation - drug effects | Gelatin - metabolism | Hydrogels - pharmacology | Bone Marrow Cells - metabolism | Serum Albumin - metabolism | Transplantation | Cell differentiation | Low density lipoproteins | Stem cells | Cell culture | Hydrogels | Mesenchyme | Liver | Gelation | Differentiation (biology) | Albumin | mRNA | α-Fetoprotein | Urea | Hepatocytes | Bone marrow | Extracellular matrix | Bone | Coating | Viability
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2008, Volume 69, Issue 3, pp. 187 - 198
Abstract Research has provided evidence that tumor growth depends on the interaction of tumor cells with stromal cells, as already suggested in 1889 by Paget....
Hematology, Oncology and Palliative Medicine | Angiogenesis | Bone marrow (BM)-derived cells | Mesenchymal stem cells (MSCs) | Tumor growth | Gene therapy | Micro-environment | DIFFERENTIATION PATHWAY | MYOCARDIAL-INFARCTION | TARGETED-DELIVERY | FACTOR RECEPTORS | PERIPHERAL-BLOOD | ENDOTHELIAL PROGENITOR CELLS | NEOVASCULARIZATION CAPACITY | ONCOLOGY | MULTIPLE LUNG-TUMORS | IN-VIVO | STROMAL CELLS | HEMATOLOGY | Animals | Stromal Cells - pathology | Humans | Bone Marrow Cells - pathology | Neoplastic Stem Cells - pathology | Cell Communication - physiology | Neoplasms - blood supply | Neovascularization, Pathologic - metabolism | Mesenchymal Stromal Cells - pathology | Neoplasms - pathology
Hematology, Oncology and Palliative Medicine | Angiogenesis | Bone marrow (BM)-derived cells | Mesenchymal stem cells (MSCs) | Tumor growth | Gene therapy | Micro-environment | DIFFERENTIATION PATHWAY | MYOCARDIAL-INFARCTION | TARGETED-DELIVERY | FACTOR RECEPTORS | PERIPHERAL-BLOOD | ENDOTHELIAL PROGENITOR CELLS | NEOVASCULARIZATION CAPACITY | ONCOLOGY | MULTIPLE LUNG-TUMORS | IN-VIVO | STROMAL CELLS | HEMATOLOGY | Animals | Stromal Cells - pathology | Humans | Bone Marrow Cells - pathology | Neoplastic Stem Cells - pathology | Cell Communication - physiology | Neoplasms - blood supply | Neovascularization, Pathologic - metabolism | Mesenchymal Stromal Cells - pathology | Neoplasms - pathology
Journal Article